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A Proof-of-Concept Study of 
Transcutaneous Magnetic Spinal 
Cord Stimulation for Neurogenic 
Bladder
Tianyi Niu1, Carol J. Bennett5,6, Tina L. Keller6, J. C. Leiter1,7 & Daniel C. Lu1,2,3,4
Patients with chronic spinal cord injury (SCI) cannot urinate at will and must empty the bladder by 
self-catheterization. We tested the hypothesis that non-invasive, transcutaneous magnetic spinal 
cord stimulation (TMSCS) would improve bladder function in individuals with SCI. Five individuals 
with American Spinal Injury Association Impairment Scale A/B, chronic SCI and detrusor sphincter 
dyssynergia enrolled in this prospective, interventional study. After a two-week assessment to 
determine effective stimulation characteristics, each patient received sixteen weekly TMSCS 
treatments and then received “sham” weekly stimulation for six weeks while bladder function was 
monitored. Bladder function improved in all five subjects, but only during and after repeated weekly 
sessions of 1 Hz TMSCS. All subjects achieved volitional urination. The volume of urine produced 
voluntarily increased from 0 cc/day to 1120 cc/day (p = 0.03); self-catheterization frequency decreased 
from 6.6/day to 2.4/day (p = 0.04); the capacity of the bladder increased from 244 ml to 404 ml 
(p = 0.02); and the average quality of life ranking increased significantly (p = 0.007). Volitional bladder 
function was re-enabled in five individuals with SCI following intermittent, non-invasive TMSCS. We 
conclude that neuromodulation of spinal micturition circuitry by TMSCS may be used to ameliorate 
bladder function.
Spinal cord injury (SCI) leads to long-term disabilities with significant social and economic consequences. After 
SCI, bladder dysfunction is common and improved bladder function consistently ranks as the top quality of life 
priority in individuals with SCI1,2. Patients with a neurogenic bladder following SCI often catheterize themselves 
to empty the bladder, and urinary tract infections and obstructive uropathies are common3–5. Direct muscle stim-
ulation6, stimulation of peripheral nerves7, or rhizotomy8 to restore bladder function all have limitations. Most of 
these interventions fail to restore the complex, orchestrated sequence of muscle contraction and relaxation that 
normal, voluntary micturition requires9.
Recently, epidural spinal cord stimulation (SCS) was used to enhance motor function in individuals with 
chronic SCI10–12. It is our hypothesis that spinal networks have the capacity to execute a range of complicated 
movements requiring detailed coordination among motor pools within the spine with minimal or even no input 
from the brain12, and electrical or magnetic stimulation of the spine restores or permits coordinated activation of 
these spinal circuits. We hypothesize that a similar mechanism of SCS to the restoration of reaching and grasping 
function may be at play with respect to bladder function whereby co-contraction of agonist-antagonist muscles 
is abolished and voluntary motor control of micturition may be restored13. Thus, SCS can be used to address 
detrusor-sphincter dyssnergia (DSD), where there is agonist/antagonist muscle co-contraction, and disinhibit or 
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enable volitional control of the spinal micturition circuit that coordinates detrusor constriction with sphincter 
relaxation.
Epidural electrical stimulation can activate micturition in rodents14, but epidural stimulation is invasive and 
costly. We were able to demonstrate recently that transcutaneous electrical stimulation of the spine can activate 
descending motor pathways non-invasively in paraplegic individuals, but such stimulation can be painful, and 
the spread of electrical current may activate other susceptible structures with adverse or painful consequences15.
Magnetic stimulation can also be used to modulate neural circuits, and with figure-eight coils, the energy 
can be targeted to some extent. Moreover, transcutaneous magnetic stimulation is non-invasive and painless. 
Transcranial magnetic stimulation (TMS) has been used to modulate neuronal function in a variety of settings 
from migraine treatment16 to depression17 to restoration of motor function after ischemic stroke18. In the current 
study, we used transcutaneous magnetic spinal cord stimulation (TMSCS) to stimulate the lumbar spine to try 
to improve bladder function in five patients with SCI who were unable to urinate voluntarily. We hypothesized 
that neuromodulation of the spine using TMSCS would allow these patients to achieve voluntary micturition and 
reduce or eliminate the need for bladder self-catheterization.
Results
Subjects underwent 3 study phases (Fig. 1). Demographic information and indices of bladder function for all 
five subjects are shown in Table 1. The magnetic resonance images (MRI) indicating the level and extent of SCI 
for each subject are shown in Fig. 2. The average duration of SCI was 8.8 ± 7.5 years. None of the subjects had 
been able to void voluntarily since the time of injury as shown in at least three prior urodynamic studies in each 
subject. 
Determining the optimal frequency: spinal function. The bulbocavernosus reflex (BCR) is disinhib-
ited and pathologically hyperactive after SCI (Fig. 3). The BCR amplitude was significantly reduced during 1 Hz 
TMSCS in all five subjects (p < 0.001). In contrast, high frequency stimulation either increased the BCR ampli-
tude or had no significant effect. The average BCR latency was 35.2 ± 5.3 ms during both 1 Hz and 30 Hz TMSCS, 
which is similar to the latency of the BCR in normal individuals19.
During 1 Hz TMSCS, spinal cord evoked potentials could be elicited in selected lower extremity muscle groups 
(perineal, vastus lateralis and quadriceps femoris); whereas we were unable to detect any spinal evoked potentials 
at 30 Hz stimulation (Fig. 3).
Determining the optimal frequency: bladder function. During the assessment phase, the urethral (P 
urethra) and detrusor pressures (P detrusor) obtained during urodynamic testing during attempted volitional 
micturition were significantly different during high and low frequency TMSCS (Fig. 4). The urethral and detrusor 
pressures are shown in Tables 2 and 3, respectively. The average urethral pressure was significantly lower than the 
baseline, unstimulated value during 1 Hz stimulation (p < 0.05) and the average urethral pressure was greater 
than the unstimulated, baseline value during 30 Hz stimulation (though this was not statistically significant 
P < 0.10). On the other hand, the average detrusor pressure was significantly elevated during 1 Hz stimulation 
compared to both the baseline, unstimulated condition and 30 Hz stimulation (P < 0.01 for both comparisons), 
and the detrusor pressure was not different from baseline conditions during 30 Hz stimulation (p = 0.5). Thus, 
stimulation at low frequency allowed each subject to elevate the bladder pressure and reduce the urethral pressure 
Figure 1. Overview of the study. There were three phases of the study: assessment, treatment and follow-up. 
The time frame for each is shown in the flow chart. During the assessment phase, each subject received 
stimulation with both 1 Hz and 30 Hz, each stimulation frequency delivered for one week, and underwent 
urodynamic testing (UDS) with video recording at the end of the assessment phase to determine the optimal 
frequency based on the changes in urethral and detrusor pressures during micturition attempts with either 
stimulating frequency. The 1 Hz stimulation frequency reduced urethral pressure and increased detrusor 
pressure in all subjects more effectively than 30 Hz stimulation. Therefore, each subject received 1 Hz 
stimulation during the treatment phase and received weekly stimulation treatment for 16 weeks. During the 
follow-up phase, the subject received “sham” stimulation at <5% intensity in order to blind each subject to 
the change in stimulation treatment. The follow-up phase lasted 6 weeks or until each subject’s urological 
improvements completely dissipated.
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(conditions conducive to urine flow), and 30 Hz stimulation had the opposite effect: urethral pressure increased 
significantly, but detrusor pressure was not modified by 30 Hz stimulation (Tables 2 and 3). Not surprisingly, 
increasing detrusor contraction and bladder pressure while simultaneously decreasing urethral pressure allowed 
voluntary micturition (Fig. 4).
Based on the BCR response, the evoked EMG activity and the responses of urethral and detrusor pressures, 
only 1 Hz TMSCS was used for weekly TMSCS during the treatment period.
Bladder function before, during and after TMSCS. All five subjects achieved at least some volitional 
urination following 16 weeks of bladder rehabilitation with TMSCS (Fig. 5). No subject achieved volitional urina-
tion until at least 4 weekly TMSCS treatments had been given, and the capacity to urinate voluntarily was restored 
in all 5 subjects on average 5.6 ± 1.5 weeks after TMSCS was begun. The capacity to urinate voluntarily was main-
tained throughout the 16-week treatment period.
Daily self-catheterization decreased from 6.6 times per day at baseline to 2.4 times per day at the conclu-
sion of the 16-week bladder rehabilitation (p = 0.04). Based on urodynamic studies conducted at the end of the 
# Sex Age
Injury 
level
ASIA 
Grade
Disease 
duration 
(years)
Mechanism 
of Injury
Length of stimulation 
until volitional 
micturition (weeks)
Decay of the 
effect duration 
(weeks)
CIC/
day Pre
CIC/
day 
Post
Volitional 
Void (Y/N)
Stream 
Velocity 
(ml/s)
Bladder 
Capacity 
Pre (ml)
Bladder 
Capacity 
Post (ml)
Daily Voiding 
Volume Post 
(ml)
A M 42 T4 A 13 MVA 4 4 9 0 Y 10 141 431 2000
B M 43 T4 A 5 Wrestling 6 3 6 3 Y 10 238 462 700
C M 22 C5 B 8 Football 5 3 6 3 Y 10 270 351 800
D M 25 C6 B 8 MVA 5 4 6 1 Y 8 215 325 1800
E M 23 C7 A 8 MVA 8 2 6 5 Y 8 354 452 300
Avg — — — — — — 5.6 3.2 6.6 2.4 — 9.3 244 404 1120
SD — — — — — — 1.5 0.8 1.3 1.9 — 1.1 78 62 740
Table 1. Demographic information, the origin and nature of the SCI and urinary indices. AIS = American 
Spinal Injury Association Impairment Scale. MVA = motor vehicle accident. CIC = clean intermittent 
catheterization.
Figure 2. T2-weighted MRI imaging showing the degree of SCI in all five subjects enrolled in the study. The 
MRIs were obtained to ensure there was no spinal cord transection and to assess the anatomical level of injury 
(cervical/thoracic/lumbar). Authors (TN and DCL) reviewed all the MRIs prior to enrolling each subject in 
the study. A synopsis of the formal neuroradiology report was reviewed and included here for reference. (A) 
Prominent metallic artifact from fusion hardware in the superior to mid thoracic spine significantly obscures 
evaluation at these levels. The small segment in which the cord can be visualized at T4-T5 demonstrates 
prominent cord myelomalacia. Stable compression deformity of T5 without retropulsion. Scattered discogenic 
changes are seen in the thoracic spine from T8 through T12 without significant foraminal or canal stenosis. 
The cord is unremarkable at these levels. (B) Metallic artifact from instrumentation hardware in upper thoracic 
spine makes the evaluation of the spinal cord difficult at high thoracic spine levels. On axial images, significant 
myelomalacia is noted at T3-4 level. Below T5, the spinal cord appears to have normal caliber. No significant 
canal or foraminal stenosis. (C) Severe spinal cord myelomalacia at C5-C6. No evidence of spinal cord edema. 
Grossly stable anterior and posterior fusion from C4 to C6. Left vertebral artery occlusion, possibly related 
to chronic traumatic dissection. (D) Status post anterior fusion from C5 to C7 and posterior fusion. Metallic 
distortion artefact is noted through the fused C5 to C7 levels and significant myelomalacia or cord edema is 
noted at these levels. Visualized upper thoracic spinal cord appears to be in normal caliber with no compression. 
(E) Status post ACDF from C6 to T1 for repair of C7 burst fracture. Spinal cord edema and swelling spans from 
C4-T1.
www.nature.com/scientificreports/
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Figure 3. An example of the BCR amplitude (A), which is measured from the perineal muscle EMG activity, 
obtained from subject C at baseline and during low frequency (1 Hz) and high frequency (30 Hz) TCSMS of 
the lumbar spine at the end of the assessment phase of the study. The BCR was elicited serially >100 times, 
and the mean (solid black line) ± 2 times the SD (cyan shading) are shown for each stimulation condition. 
The average and standard deviation of BCR responses to 1 and 30 Hz TCSMS (B), expressed as a percent of 
the baseline value in each subject, are shown to illustrate that the BCR amplitude was significantly reduced 
during 1 Hz TCSMS compared to 30 Hz TCSMS. Student’s t-test: *p < 0.0001, n.s. = non-significant, N = 100 
BCR cycles. BCR = bulbocavernosus reflex. Examples of evoked EMG activity from a single subject in selected 
muscles are shown in C. Lumbar TCSMS at 1 Hz elicited significant EMG activity, but 30 Hz TCSMS did not 
alter EMG activity. Ensemble averages of EMG activity (solid black line) ± 2 times the SD (cyan shading) were 
derived from greater than 100 cycles of stimulation. The stimulus artifacts are shown in the 30 Hz stimulation 
sequences since stimulation occurred multiple times within the recording window (large black spikes). The left 
(L) perineum, left vastus lateralis, right (R) vastus lateralis and left quadriceps femoris muscles were recorded. 
The arrows in panel A represent the peak and the nadir of the BCR.
www.nature.com/scientificreports/
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TMSCS treatment, the average volume of urine generated voluntarily increased from 0 cc/day to 1120 cc/day 
(p = 0.03), and the subjects were able to generate significant urine stream velocities, which rose on average from 0 
cc/sec to 9.3 cc/sec (p < 0.001). The bladder capacity increased from 244 ml to 404 ml (p = 0.02). Sexual function 
also improved from 9 to 20 as measured by Sexual Health Inventory for Men (SHIM) (p = 0.0003). The subjects 
enjoyed a much higher quality of life; the average i-QOL score rose from 47 to 82 (p = 0.007, Fig. 4). While all 
five subjects had improved bladder function and were able to achieve volitional micturition, their responses to 
TMSCS varied (the responsiveness order was A > D > B = C > E). This variation did not appear to be the result of 
differences in their AIS. (Table 1).
The average time that volitional micturition was maintained after the sham stimulation began was 3.2 ± 0.8 
weeks. Follow-up diary entries confirmed that the ability to void voluntarily rapidly decayed in all subjects after 
Figure 4. Examples of video urodynamics are shown from patient A (panels A – before the 16-week TMSCS 
treatment and D – after the 16 week TMSCS treatment). The first video images in each sequence show the pre-
voiding bladder capacity, which increased after TMSCS. The second images show the initiation of volitional 
voiding and opening the bladder neck (white arrows), and the final images show the post-void residuals. In 
panel B, examples of urine flow (red line); urethral pressure (black line) and detrusor pressure (blue line) are 
shown before (upper graph) and after the 16-week TCSMS treatment (lower graph). Note that detrusor pressure 
remained below urethral pressure before TMSCS, and no urine flow was generated; whereas detrusor pressure 
exceeded urethral pressure and urine flow was generated after 16 weeks of TMSCS. The average urethral and 
detrusor pressures ± SD obtained during efforts to void at the end of the assessment phase are shown in panel 
C during baseline and 1 and 30 Hz TMSCS. The detrusor pressure rose significantly and the urethral pressure 
fell significantly only during 1 Hz TMSCS compared to the non-stimulated condition and the 30 Hz condition 
(**p < 0.0001), but the baseline, unstimulated state and the 30 Hz condition did not differ from each other 
based on an ANOVA and specific comparisons using Tukey’s HSD.
www.nature.com/scientificreports/
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the cessation of effective TMSCS, and no subject maintained the capacity for voluntary micturition five weeks 
after the last effective stimulation.
Discussion
Voluntary micturition requires complex, orchestrated neuromuscular control of the urinary bladder by sensory, 
motor and autonomic systems. During voluntary micturition, sympathetic inhibition of bladder contraction is 
withdrawn, parasympathetic activation of the detrusor contraction emerges to increase vesicular pressure, and 
contraction of the urethral sphincter is inhibited to allow urine to flow out of the bladder. This control is achieved 
through fronto-pontine-spinal cord projections to parasympathetic ganglia in the abdomen and to sympathetic 
and somatic neurons in the caudal spine. In individuals with SCI, coordination among parasympathetic, sym-
pathetic and somatic nerve activities is lost: bladder pressure is elevated, but the bladder cannot be completely 
emptied because contraction of the external sphincter is not inhibited. Patients with SCI must perform multiple 
bladder self-catheterizations each day to evacuate urine and to prevent kidney injury due to high pressure; which 
increase the risk and frequency of infection and traumatic injury to the urethra. Any decrease in catheterization 
frequency, which was achieved in all study subjects, represents a potential decrease in complications associated 
with catheterization.
Isolated regions of lumbosacral spinal cord contain circuits that are capable of carrying out complex motor 
activities20,21. Furthermore, spinal cord injury in most motor complete, AIS A and B SCI subjects is not anatomi-
cally complete, and many spinal circuits remain intact, especially those below the level of the spinal cord injury22. 
In both animal and human subjects with chronic paralysis from SCI, motor movements have improved after inva-
sive, epidural, electrical stimulation10–12. In this study, we hypothesized that the spinal micturition circuit remains 
intact in subjects with SCI, and since this circuit is semiautonomous, we should be able to enhance activation 
of patterned muscle activities controlled by these circuits and activate or modulate them using TMSCS over the 
thoracolumbar spine. The mechanism of action appears to be similar to the use of stimulation to improve upper 
extremity function in which the threshold of motor circuit activation is diminished to enable volitional, coor-
dinated agonist-antagonist muscle activity13. Voluntary bladder control was restored to some extent by TMSCS 
in all five individuals with chronic SCI. Four out of five subjects (80%) were able to decrease the frequency of 
self-catheterization by at least 50%. One subject was able to void normally without any self-catheterization while 
another subject only needed one catheterization each day (Table 1).
Other attempts to restore urination in SCI patients by stimulating multiple peripheral nerves, specifically the 
pudendal, pelvic, hypogastric and tibial nerves23–25, did not consistently improve bladder function. Furthermore, 
sacral nerve modulation requires electrode implantation, which is invasive and risky26,27. TMSCS differs in that 
Δ P ure (mmHg) No stimulation (NoS) Low frequency (1 Hz) High frequency (30 Hz)
Subject A 28.4 ± 5.0 −25.3 ± 2.7 36.2 ± 11.1
Subject B 2.5 ± 4.8 0.4 ± 5.2 50.3 ± 17.0
Subject C 19.8 ± 3.4 −8.3 ± 6.3 20.0 ± 10.0
Subject D 18.9 ± 1.5 5.6 ± 7.3 27.6 ± 4.1
Subject E 15.3 ± 5.2 −0.9 ± 9.6 46.6 ± 11.1
Average 17.0 ± 9.4 −5.7 ± 12.0 1 Hz vs NoS p < 0.05 1 Hz vs 30 Hz p < 0.001 36.1 ± 12.7 30 Hz vs NoS p < 0.10
Table 2. At the end of the assessment phase, changes in urethral pressure in five subjects during micturition 
attempts compared to the pre-attempt baseline. Positive numbers indicate an increase in the pressure during 
the attempts while negative numbers indicate a decrease in the urethral pressure during the attempts. Notice 
that high frequency stimulation (30 Hz) resulted in increased/unchanged urethral pressure during attempted 
micturition when compared to the no-stimulation/baseline; low frequency stimulation (1 Hz), on the other 
hand, significant decreased urethral pressure compared to both unstimulated and 30 Hz stimulation conditions.
Δ P det (mmHg) No stimulation Low frequency (1 Hz) High frequency (30 Hz)
Subject A 19.4 ± 2.2 38.8 ± 0.9 24.5 ± 4.5
Subject B 26.1 ± 1.5 28.2 ± 3.7 0.6 ± 1.3
Subject C 1.3 ± 0.6 30.4 ± 4.3 1.3 ± 0.9
Subject D 3.0 ± 1.5 49.4 ± 19.5 1.6 ± 0.8
Subject E −1.1 ± 0.7 58.5 ± 9.4 −0.1 ± 0.7
Average 9.7 ± 12.2 41.1 ± 12.8 1 Hz vs NoS p < 0.001 1 Hz vs 30 Hz p < 0.001 5.6 ± 10.6 30 Hz vs NoS p = 0.50
Table 3. At the end of the assessment phase, the change in detrusor pressure in five subjects during micturition 
attempts compared to the pre-attempt baseline. Positive numbers indicate an increase in the pressure during 
the attempts while negative numbers indicate a decrease in the pressure during the attempts. Notice that 
high frequency stimulation (30 Hz) did not change in detrusor pressure during attempted micturition when 
compared to the no-stimulation/baseline; low frequency stimulation (1 Hz), on the other hand, significantly 
increased detrusor pressure compared to the non-stimulated and 30 Hz conditions.
www.nature.com/scientificreports/
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it is non-invasive and painless in patients with SCI. In addition, TMSCS provides more consistent and effective 
bladder emptying than existing epidural stimulation of selected peripheral nerves6–8.
We believe that TMSCS allowed volitional activation of a coordinated pattern of parasympathetic withdrawal 
and sympathetic activation and somatic muscle inhibition as demonstrated in urodynamic studies. While the 
precise mechanism of TMSCS remains unknown, the coordinated activity of detrusor and sphincter muscles 
suggests that TMSCS works by activating or enhancing activation of central pattern generating circuits within 
the lumbosacral spinal cord and does not rely solely on activation of motor neurons or peripheral nerves. This 
Figure 5. Summary of urological functions for all five subjects and average daily volitional micturition volume 
for all five subjects during follow-up phase; all changes were statistical significant when tested with paired t-tests 
(p < 0.05; see Results for details). The top panel shows the timing of recovery and loss of voluntary control of 
micturition and the volume of urine produced each day as a function of time. All five subjects recovered the 
capacity to urinate voluntarily, and about 2–3 weeks after the termination of TMSCS, the capacity to urinate 
voluntarily declined rapidly back to the baseline (unable to void voluntarily). The remaining panels indicate the 
initial value of each variable before the start of TMSCS and after 16 weeks of TMSCS. The urine stream velocity 
and the bladder capacity (both measured during urodynamic studies) increased significantly (p < 0.05) after 
16 weeks of TMSCS. The residual volume and the number of self-catheterizations diminished significantly 
(p < 0.05, for both variables), and the SHIM Score and the iQOL, both quality of life measures, increased 
significantly (p < 0.05) after 16 weeks of TMSCS.
www.nature.com/scientificreports/
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hypothesis receives further support from the divergent responses to TMSCS at 1 Hz and 30 Hz: 1 Hz TMSCS 
resulted in decreased urethral pressure, increased detrusor pressure and micturition, as opposed to 30 Hz TMSCS, 
which increased urethral pressure, decreased detrusor pressure and enhanced urine storage within the bladder. 
The different stimulation frequencies elicited different bladder behaviors as if different central pattern generators 
(CPGs) or different aspects of a micturition CPG were activated. These divergent responses suggest that TMSCS 
may be applicable to a broader range of conditions such as hyperactive bladder, which may benefit from higher 
frequency stimulation.
We selected patients with detrusor-sphincter dyssynergia specifically because this is the group of SCI patients 
most recalcitrant to treatment. A regular schedule of self-catheterization prevents ureteral reflux and the develop-
ment of obstructive uropathy and chronic renal failure, but frequent catheterization has risks of its own: infection, 
creation of false passages, urethral stricture28,29, a reduced quality of life, and a loss of independence. Improving 
quality of life is our ultimate goal using TMSCS, but this cannot be achieved if the risk of ureteral reflux and 
chronic renal failure increases. Therefore, any benefits of TMSCS, such as a more physiological voiding sequence 
with low storage pressures and increased bladder capacity and a better coordination of increased detrusor compli-
ance and reduced external sphincter pressures that enable unobstructed voiding in a low pressure system, will be 
beneficial in the long term only if ureteral reflux is not increased. Video urodynamics performed at the initiation 
and termination of our study demonstrated no evidence of reflux. While this was a proof of concept, pilot study 
with patients followed for 16 weeks, additional studies are needed in an expanded cohort with extended follow-up 
to ensure that stable bladder and renal function are maintained when TMSCS is used to increase voluntary mic-
turition and reduce the frequency of self-catheterization.
The BCR is a polysynaptic reflex, and BCR amplitudes in our subjects were 10 to 100 times larger at baseline 
than in normal individuals. Hyperactivity of the BCR may be analogous to the hyperactivity of tendon reflexes 
following SCI and suggests that subjects with SCI have decreased supraspinal inhibition of the BCR. During 
low frequency TMSCS, the amplitude of the BCR decreased, from which we infer that TMSCS induced greater 
inhibition of the BCR. Magnetic stimulation may achieve these effects by modulation of spinal interneurons via 
dorsal root ganglion or dorsal column stimulation, which is a putative mechanism of action for epidural spinal 
cord stimulation30, or TMSCS may modulate responses within the sympathetic chain and sacral parasympathetic 
centers and facilitate the process of micturition.
Improvements in urinary function were not instantaneous; progressive improvement became apparent over 
the course of the study. Initially, simultaneous measurements of urethral and bladder pressures during volitional 
urination attempts revealed little (if any) sustained bladder contraction and persistently elevated urethral pres-
sures, but after completion of at least 4 weeks of effective TMSCS, subjects became better able to generate sus-
tained bladder contractions although detrusor-sphincter dyssynergia persisted (increased bladder pressures, but 
also increased urethral pressures, which prevented bladder emptying). At the end of the 16-week rehabilitation 
period, subjects were able to produce voluntary, coordinated bladder contractions with high detrusor pressures 
and reduced urethral pressures. Since bladder pressure exceed urethral pressure, urine flow velocity was increased 
and significantly higher urine volumes were achieved (Fig. 2).
Our subjects were able to urinate voluntarily in between treatment sessions when magnetic stimulation was 
not present. We believe that TMSCS persistently raised the activation state (or reduced inhibition) of the mictu-
rition circuit so that residual neural pathways between the supraspinal micturition centers and lumbosacral mic-
turition central pattern generators were re-invigorated, which is consistent with previous findings using epidural 
stimulation to enhance recovery of motor function12. Restoration of voluntary micturition required repetitive 
TMSCS over at least 4 weeks. The benefits of epidural electric stimulations on motor function also required 3–5 
sessions/weeks before improvements in motor functions were seen12. Once supraspinal to spinal communication 
had been restored or re-enabled by TMSCS, it remained enabled so long as the subject received some minimal 
amount of TMSCS during each weekly treatment session, but the benefits of TMSCS were not permanent. All 
subjects lost the ability to control micturition soon after the termination of effective TMSCS (Fig. 5). The tempo-
ral dynamics of the onset and offset of benefit of TMSCS are consistent with remodeling of the spinal circuitry 
in which some relatively slow neuronal or circuit remodeling is required to re-establish effective synaptic or 
supraspinal communication31–33, and some aspect of TMSCS was necessary between periods of volitional bladder 
emptying to maintain the integrity of communication between supraspinal and lumbar micturition circuits. The 
once weekly treatment interval and stimulation protocol represent a surprisingly small recurrent input to main-
tain volitional micturition, but this schedule is feasible for patients, and TMSCS could be administered in weekly 
physical therapy sessions at low cost. In any event, neuronal plasticity or remodeling are well recognized in TMS 
studies, specifically with low frequency (1 Hz) stimulation34,35. These results and our study of hand function12 
provide two examples of the capacity of neuromodulation of spinal circuits to enable volitional control of motor 
functions below the level of SCI.
The responses to TMSCS varied among our five subjects. While we do not have a precise explanation for this, 
we know that the variation was not a result of differences among the AIS (Subject A, B, E were all category A, but 
subject A improved much more than the other two). The reasons for the variation are likely multifactorial, but 
perhaps most importantly, our subjects have variable amounts of residual spinal function. The current AIS is not 
sensitive to the subtleties of residual spinal functions among subjects.
The main limitations of our study are its small size and the lack of proof of the actual mechanism of action. As 
this is a pilot study, we plan to continue to expand the study and enroll additional subjects. Further studies will 
focus on the molecular and cellular processes that follow magnetic stimulation to investigate the precise mecha-
nism of action of magnetic stimulation.
www.nature.com/scientificreports/
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Methods
Subject selection. We conducted a pilot, prospective, interventional study in five subjects. All aspects of the 
study were approved by the UCLA IRB (IRB# 14-000932) and filed with ClinicalTrials.gov (registration number: 
NCT02331979, date of registration: 06/01/2015). All methods were performed in accordance with the relevant 
guidelines and regulations as stipulated by UCLA IRB. Informed consent was obtained prior to subject partic-
ipation. The inclusion criteria for the study were male age 18–75, a stable American Spinal Injury Association 
Impairment Scale (AIS) A/B, motor complete spinal cord injury between spinal levels C2-T8 present for greater 
than 1 year, and a documented history of neurogenic bladder requiring intermittent catheterization. Each subject 
was required to have at least three prior urodynamic studies to confirm the diagnosis of neurogenic bladder with 
detrusor sphincter dyssynergia (DSD), which was diagnosed with urodynamic study in which a rise in detrusor 
pressure and concomitant needle EMG activity and rise in urethral pressure were demonstrated (see Tables 2 and 
3). Patients with a history of autonomic dysreflexia were excluded from the study. Any patient who was ventilator 
dependent, abusing drugs, had musculoskeletal dysfunction (i.e., unstable fractures), cardiopulmonary diseases, 
active infections or ongoing depression requiring treatment, or had previous exposure to and use of spinal cord 
stimulation was excluded from the study. Patients with a history of bladder botox injection or bladder/sphincter 
surgeries were excluded. Five subjects were recruited and completed the study. There was no subject attrition.
Intervention. Each study subject underwent baseline urodynamic testing (UDS) at the beginning of the study 
to confirm the diagnosis of a neurogenic bladder with DSD and establish baseline bladder functions. The study 
was divided into three phases: an Assessment phase (2 weeks), a Treatment phase (16 weeks) and a Follow-up 
phase (6 weeks). During the Assessment phase, each subject underwent once/week transcutaneous magnetic 
spinal cord stimulation (TMSCS) at both 1 Hz (low) and 30 Hz (high) frequency (40–60% intensity) over the 
lumbar spine (described below). 1 Hz and 30 Hz were both administered during the assessment phase because 
the optimal stimulation frequency in human subjects was unknown to us prior to this study. The two frequencies 
were administered in random order. These frequencies was chosen based on previous results in animals in which 
low frequency stimulation promoted and high frequency stimulation inhibited micturition in animals with SCI13. 
At the conclusion of the Assessment phase, each subject underwent another UDS to determine the better stim-
ulation frequency (the characteristics of optimal stimulation are defined below). Once the better frequency was 
established (and it turned out that 1 Hz was better than 30 Hz stimulation in all five subjects), each subject entered 
the treatment phase of the study and received weekly transcutaneous lumbar spinal cord magnetic stimulation 
for a total of 16 weeks (described below). This 16-week period of TMSCS constituted bladder rehabilitation. 
Each subject received non-video urodynamic testing once every four weeks during the treatment phase to mon-
itor progress and insure that bladder function was not further impaired. After the initial four-week stimulation 
period, each subject was asked to attempt volitional urination for 5–10 minutes prior to bladder catheterization. 
The subjects were instructed to keep the environment quiet, relax and focus on voiding. Specifically, they were 
instructed to perform no straining/Valsalva maneuver, external compression by Crede maneuver, reflex trigger-
ing by tapping, anal stretch, or pushing. Attempts were limited to 10 minutes. Each subject was given a urine/stool 
specimen collection pan (Medline DYND36600H, Mundelein, IL) to collect any volitional urinary output. In 
order to prevent potential urinary retention, the subjects were asked to self-catheterize after the volitional attempt 
and to record the catheterization output. The urinary output and the volume of the residual urine in the bladder 
(collected after attempted void by each patient’s routine bladder catheterization) were recorded in a diary after 
every attempt to urinate voluntarily. Each subject was also asked to record any other changes that he may have 
noticed in the diary throughout the study period. During the follow-up period, sham transcutaneous magnetic 
stimulation (sham) was employed at reduced intensity (5%), which replicated the auditory, partial sensory and 
mechanical cues of real stimulation. Each subject was instructed to continue to attempt to urinate voluntarily as 
he had during the treatment phase, and each subject continued to keep a detailed urological lifestyle diary until 
the end of the follow-up phase (Fig. 1).
Each subject was also given an incontinence quality of life (iQOL) questionnaire to complete prior to the start 
of the study and at the end of the 16-week treatment stimulation. iQOL has been validated in multiple urological 
quality of life studies in patients with SCI36,37. Sexual functions were assessed by Sexual Health Inventory for Men 
(SHIM) questionnaire38 at the beginning of the study and at the end of 16-week treatment phase.
Blinding. The state of knowledge at the start of the study, in which we did not know the effective parameters 
of stimulation to effect micturition, precluded a randomized trial. Therefore, we conducted a single arm study 
in which each subject acted as his own control. Additionally, a sham phase was conducted at the end after stim-
ulation because there was exposure to stimulation during initial Assessment Phase (we had no initial, baseline, 
non-stimulated collection period), and we were unsure of the wash-out period for this exposure due to the pilot 
nature of this study. However, subjects and experimenters were blinded throughout the process in the assessment, 
treatment and follow-up phases. Given that these spinal cord injury patients have diminished/no sensation due 
to their injuries, The subjects did not feel any sensations at 1 Hz or 30 Hz at the level of stimulation used during 
treatment as they have muted sensory capacity due to their spinal cord injury. We purposefully selected a rela-
tively low intensity stimulus to avoid any painful sensations, and the stimulation level was below the sensory and 
motor threshold. The subjects did hear a “click” during each stimulation (especially at 1 Hz when the click was 
very predicable). This auditory cue was re-created during sham stimulation as well. Approximately from T11-L3 
level. The coil dimensions are 172 × 92 × 51 mm in a figure-of-eight formation with two rings each 75 mm in 
diameter. The target (focality) is the center of the figure of eight, which in our case is T12-L1 area, which over-
lies the conus medullaris in humans. We used a research coil (with identical sham and treatment faces), which 
allowed blinding of both experimenter and subject; thereby double blinding the follow-up phase of the study. 
The staff member responsible for controlling of the stimulator and the dose of stimulation was not blinded as the 
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stimulation parameters were manipulated during the various phases of the study; however, this person did not 
interact with the subject (he sat behind a curtain), and each staff member was instructed to follow the same script 
when administering the various tasks regardless of the particular stimulation values used. To assess integrity of 
blinding, we asked subjects at the conclusion of the study what each study phases consisted of; their responses 
were no better than chance.
Urodynamic testing. We employed a commercially available urodynamic machine (Laborie Aquarius® XT, 
Laborie International, Mississauga, ON, Canada). Prior to the urodynamic testing, each subject emptied his blad-
der by direct catheterization. The volume of urine was recorded. The patient was then placed in a supine position 
and a triple lumen catheter (TLC-7M, Laborie International, Mississauga, ON, Canada) was inserted. Two needle 
recording electrodes (1512A-M, Laborie International, Mississauga, ON, Canada) were inserted bilaterally into 
the perineal muscles approximately halfway between the base of the scrotum and anus and 1 cm lateral to the 
midline. An EMG grounding pad was placed on the knee joint. A rectal catheter (RPC-9, Laborie International, 
Mississauga, ON, Canada) was inserted to record abdominal pressure. The subject was next placed in a left decu-
bitus position. A condom catheter was used to collect any urine output, which was directed through a funnel into 
a graduated cylinder (DIS173, Laborie International, Mississauga, ON, Canada) on a scale (UROCAP IV, Laborie 
International, Mississauga, ON, Canada) to record the volume of urine produced and the stream velocity.
Transcutaneous magnetic stimulation. A MagVenture Magnetic Stimulator (MagPro R30, Atlanta, 
GA) with an active/placebo figure-8 research coil (Cool-B65 A/P Coil) was used for all transcutaneous magnetic 
stimulation sessions. The spinous processes of the lower vertebrae in each subject were palpated, and thoracic 11 
to lumbar 4 vertebrae were marked. The coil was centered along the midline at the L1 vertebral level during the 
stimulation and oriented such that the magnetic field generated was parallel to the spinal cord (rostral-caudal). 
We used trains of biphasic, single pulse (duration 250 µs), continuous, magnetic stimulation. Each stimulation 
session consisted of three 4-min continuous stimulation periods with a 30 second break between each stimulation 
period for a total of 13 minutes (a total of 12 minutes of stimulation plus 1 minute of breaks). For the first two 
weeks, each subject underwent stimulation at 1 Hz and 30 Hz frequencies (week one: 1 Hz/30 Hz/1 Hz, and week 
two: 30 Hz/1 Hz/30 Hz) until the better frequency was determined for the patient at the first follow-up UDS after 
the 2nd week of stimulation. The frequency of 1 Hz and 30 Hz was selected based on our previous work in animals 
and humans12,14. Changes in urethral (directly measured) and detrusor (vesicular – abdominal) pressures during 
micturition attempts were measured during both low frequency stimulation (1 Hz) and high frequency stimu-
lation (30 Hz). The stimulation frequency that resulted in the combination of increased detrusor pressure and 
decreased urethral pressure during attempted micturition (hence, promoting bladder emptying) was selected as 
optimal. The intensity of stimulation was set 20% below the intensity that elicited local paraspinal muscular con-
traction for each subject (since muscle contractions would have unmasked the double blinding). This stimulation 
intensity was usually around 40–50% of the maximal field strength of 2 Tesla. Once the optimal frequency was 
determined, all subjects received the optimal stimulation frequency only at a constant intensity for the remaining 
16, weekly bladder rehabilitation sessions.
Electrophysiology. At the end of the assessment phase, the following electrophysiological data were 
obtained on each subject before, during and after low frequency (1 Hz) and high frequency (30 Hz) transcutane-
ous magnetic stimulation: bulbocavernosus reflex (BCR), electromyography (EMG) and spinal evoked potentials 
(SEP) bilaterally in the pelvic floor and in the vastus lateralis, gastrocnemius, gluteus and quadriceps femoris 
muscles.
Pelvic floor EMGs were obtained using needle electrodes (Laborie 1512A-M, Laborie International, 
Mississauga, ON, Canada). All other muscle EMGs were obtained with 1 inch surface pad electrodes 
(MultiBioSensors, El Paso, TX).
The BCR was obtained by using ring stimulating electrodes (Cadwell 302243-200, Cadwell Industries, 
Kennewick, WA) that were stimulated with a monophasic electric pulse at 1.5 Hz, pulse width 0.2 ms, and inten-
sity at three times the sensory threshold (or 35 mA if the subject had no sensation). At least 100 pulses were given 
in each BCR test session.
Recording, amplification and digitization of all data were done using an RZ2 amplifier and a PZ5–32 TDT 
digitizer (Tucker Davis Technologies, Alachua, FL) with a 60 Hz notch filter and band pass filtering to exclude 
frequencies <3 Hz and > 200 Hz.
Data Analysis. The primary outcome was voluntary urination volume per day. Pre-specified secondary 
outcomes included urine stream flow rate, bladder capacity, catheterizations per day, sexual health inventory 
for men (SHIM), and urinary incontinence quality of life scale (iQOL). All electrophysiological data from the 
TDT system (Tucker Davis Technologies, Alachua, FL) were exported to a computer and analyzed using MatLab 
(Matlab2015b, MathWorks, Natick, MA). The BCR amplitudes and latency were calculated for every single elec-
trical pudendal stimulation. Spinal evoked potentials (if present) were identified in the continuous recording of 
lower extremity EMGs.
Urodynamic data were exported from the Laborie system and analyzed using Microsoft Excel (Excel2010, 
Microsoft, Redmond, WA). The changes in urethral pressure (P urethra) and detrusor pressure (P detrusor) were 
measured and compared during baseline and during attempted micturition.
Statistical significance was assessed with Analysis of Variance (ANOVA) and paired Student’s T-tests and 
the Bonferroni correction for multiple preplanned comparisons, when appropriate, using R 3.25 (https://
www.r-project.org) and Graphpad Prism (Graphpad Software, La Jolla, CA), respectively.
www.nature.com/scientificreports/
1 1Scientific REPORTS |  (2018) 8:12549  | DOI:10.1038/s41598-018-30232-z
Data Availability. All data generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request. For further details of study protocol please see Supplementary 
Information.
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